---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-044454"
form_type: "8-K"
ticker: "AIMD"
cik: "0001014763"
company_name: "Ainos, Inc."
filed_at: "2026-09-28T12:00:27+00:00"
generated_at: "2026-10-12T13:30:46.341721+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ainos licenses VELDONA worldwide to BioPhoenix; $600K upfront, up to ~$10M in fees plus 25% sublicense revenue

## Summary
- Ainos granted BioPhoenix an exclusive, worldwide license to VELDONA for Sjögren's disease and thrombocytopenia; $600,000 upfront fee due within 15 business days after delivery conditions.
- BioPhoenix pays a one-time first-sublicense fee and 25% of applicable net sublicensing revenue; licensing all 15 additional indications would bring total fees to ~$10.0M.
- BioPhoenix funds and executes clinical/regulatory development, reducing Ainos' independent capital needs; Ainos retains platform ownership and prioritizes AI Nose/Chemical Intelligence.
- Ainos is barred from competing in the licensed indications worldwide during the term and for 10 years after; term runs to later of last patent expiry or 20 years post-9/24/2026.
- VELDONA history: 68 studies (3 Phase I, 63 Phase II, 2 Phase III), 16 indications, ~6,000 participants; Sjögren's had ~497 patients in two Phase III trials.

## SEC filing metadata
- accession: 0001493152-26-044454
- form_type: 8-K
- ticker: AIMD
- cik: 0001014763
- company_name: Ainos, Inc.
- filed_at: 2026-09-28T12:00:27+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1014763/000149315226044454/0001493152-26-044454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1014763/000149315226044454/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-044454
- JSON: https://secwatch.observer/filing/0001493152-26-044454.json
- Plain text: https://secwatch.observer/filing/0001493152-26-044454.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.